Skip Navigation

Vaccine Safety Bibliography - May 2009

  1. Progress Toward Interruption of Wild Poliovirus Transmission--Worldwide, 2008.   MMWR Morb Mortal Wkly Rep; 58 (12): 308-312; April 3, 2009.

  2. FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine.   MMWR Morb Mortal Wkly Rep; 58 (14): 374-375; April 17, 2009.

  3. [Polish Gynaecological Society Guidelines for Human Papilloma Virus (HPV) Vaccination].   Ginekol Pol; 80 (2): 139-146; February, 2009.

  4. [Allergy and Vaccination].   Patol Fiziol Eksp Ter; (1): 5-8; January, 2009.

  5. Use of Northern Hemisphere Influenza Vaccines by Travelers to the Southern Hemisphere.   MMWR Morb Mortal Wkly Rep; 58 (12): 312; April 3, 2009.

  6. Updated Immunization Recommendations for Children.   Child Health Alert; 27: 3; February, 2009.

  7. Abarca, V. K.; Cerda, L. J.; Ferreccio, R. C.  [Adverse Reactions to Diphtheria-Pertussis-Tetanus Vaccine in the Chilean Immunization Program].   Rev Med Chil; 137 (1): 10-17; January, 2009.

  8. Abdel Razek, A.; Az El-Dein, N.  Effect of Breast-Feeding on Pain Relief During Infant Immunization Injections.   Int J Nurs Pract; 15 (2): 99-104; April, 2009.

  9. Antunes, H.; Afonso, A.; Iturriza, M.; Martinho, I.; Ribeiro, C.; Rocha, S.; Magalhaes, C.; Carvalho, L.; Branca, F.; Gray, J.  G2P[4] the Most Prevalent Rotavirus Genotype in 2007 Winter Season in an European Non-Vaccinated Population.   J Clin Virol; 45 (1): 76-78; May, 2009.

  10. Ball, R.; Shadomy, S. V.; Meyer, A.; Huber, B. T.; Leffell, M. S.; Zachary, A.; Belotto, M.; Hilton, E.; Bryant-Genevier, M.; Schriefer, M. E.; Miller, F. W.; Braun, M. M.  HLA Type and Immune Response to Borrelia Burgdorferi Outer Surface Protein a in People in Whom Arthritis Developed After Lyme Disease Vaccination.   Arthritis Rheum; 60 (4): 1179-1186; April, 2009.

  11. Beran, J.; Ambrozaitis, A.; Laiskonis, A.; Mickuviene, N.; Bacart, P.; Calozet, Y.; Demanet, E.; Heijmans, S.; Van, Belle P.; Weber, F.; Salamand, C.  Intradermal Influenza Vaccination of Healthy Adults Using a New Microinjection System: a 3-Year Randomised Controlled Safety and Immunogenicity Trial.   BMC Med; 7: 13; April 2, 2009.

  12. Blank, P. R.; Szucs, T. D.  Increasing Influenza Vaccination Coverage in Recommended Population Groups in Europe.   Expert Rev Vaccines; 8 (4): 425-433; April, 2009.

  13. Brantsaeter, A. B.; Romanus, V.; Andersen, P. H.; Heldal, E.  Evidence of Protective Effect of BCG Vaccination in Persons at Low Risk of Tuberculosis in Nordic Countries.   Int J Tuberc Lung Dis; 13 (4): 440-445; April, 2009.

  14. Brenneman, A. E.  Adult Immunization: the 2009 Vaccine Schedules.   JAAPA; 22 (3): 15-17; March, 2009.

  15. Brotherton, J. M.; Deeks, S. L.; Campbell-Lloyd, S.; Misrachi, A.; Passaris, I.; Peterson, K.; Pitcher, H.; Scully, M.; Watson, M.; Webby, R.  Interim Estimates of Human Papillomavirus Vaccination Coverage in the School-Based Program in Australia.   Commun Dis Intell; 32 (4): 457-461; December, 2008.

  16. Burton, C.; Vaudry, W.; Moore, D.; Scheifele, D.; Bettinger, J.; Halperin, S.; Tam, T.; Law, B.  Children Hospitalized With Influenza During the 2006-2007 Season: a Report From the Canadian Immunization Monitoring Program, Active (IMPACT).   Can Commun Dis Rep; 34 (12): 17-32; December, 2008.

  17. Castella, A.; Argentero, P. A.; Lanszweert, A.  [Factors Influencing Uptake of Influenza Vaccination in Healthcare Workers. Findings From a Study in a General Hospital].   Ann Ig; 21 (1): 35-40; January, 2009.

  18. Caubet, J. C.; Siegrist, C. A.; Eigenmann, P. A.  [Allergic Reactions and Vaccines: Distinguishing True and False Reactions].   Rev Med Suisse; 5 (191): 416-419; February 18, 2009.

  19. Chan, S. S.; Yan Ng, B. H.; Lo, W. K.; Cheung, T. H.; Hung Chung, T. K.  Adolescent Girls' Attitudes on Human Papillomavirus Vaccination.   J Pediatr Adolesc Gynecol; 22 (2): 85-90; April, 2009.

  20. Cordonnier, C.; Labopin, M.; Chesnel, V.; Ribaud, P.; De La, Camara R.; Martino, R.; Ullmann, A. J.; Parkkali, T.; Locasciulli, A.; Yakouben, K.; Pauksens, K.; Einsele, H.; Niederwieser, D.; Apperley, J.; Ljungman, P.  Randomized Study of Early Versus Late Immunization With Pneumococcal Conjugate Vaccine After Allogeneic Stem Cell Transplantation.   Clin Infect Dis; 48 (10): 1392-1401; May 15, 2009.

  21. Cox, L. S.  Shooting for a Faster Approach to the Immunotherapy Target: Will Cluster Become Conventional?   Ann Allergy Asthma Immunol; 102 (3): 177-178; March, 2009.

  22. D'Ancona, F.  VENICE II: Go on Combining Our Efforts Towards a European Common Vaccination Policy!   Euro Surveill; 14 (12): 19161; March 26, 2009.

  23. Dalpke, A. H.  [Immunological Basics of Vaccination].   Dtsch Med Wochenschr; 134 (Suppl 2): S61-S64; April, 2009.

  24. de Greeff, S. C.; Lugner, A. K.; van den Heuvel, D. M.; Mooi, F. R.; de Melker, H. E.  Economic Analysis of Pertussis Illness in the Dutch Population: Implications for Current and Future Vaccination Strategies.   Vaccine; 27 (13): 1932-1937; March 18, 2009.

  25. de Lataillade, C.; Auvergne, S.; Delannoy, I.  2005 and 2006 Seasonal Influenza Vaccination Coverage Rates in 10 Countries in Africa, Asia Pacific, Europe, Latin America and the Middle East.   J Public Health Policy; 30 (1): 83-101; April, 2009.

  26. Dempsey, A. F.; Abraham, L. M.; Dalton, V.; Ruffin, M.  Understanding the Reasons Why Mothers Do or Do Not Have Their Adolescent Daughters Vaccinated Against Human Papillomavirus.   Ann Epidemiol; April 24, 2009. [Epub ahead of print].

  27. Die-Kacou, H.; Yavo, J. C.; Kakou, K. A.; Kamagate, M.; Balayssac, E.; Daubrey, P. T.; Gboignon, V. M.  [Post-Vaccinal Adverse Effects Monitoring During National Campaign of Vaccination Against Measles in Cote D'Ivoire].   Bull Soc Pathol Exot; 102 (1): 21-25; February, 2009.

  28. Doren, M.; Gerhardus, A.; Gerlach, F. M.; Hornberg, C.; Kochen, M. M.; Kolip, P.; Ludwig, W. D.; Muhlhauser, I.; Razum, O.; Rosenbrock, R.; Schach, C.; Schmacke, N.; Windeler, J.  [Scientists Call for a Reevaluation of HPV Vaccination and an End to the Misleading Information].   Pharm Unserer Zeit; 38 (2): 186-187; 2009.

  29. Endrich, M. M.; Blank, P. R.; Szucs, T. D.  Influenza Vaccination Uptake and Socioeconomic Determinants in Eleven European Countries.   Vaccine; April, 2009. [Epub ahead of print].

  30. Fiorante, S.; Lopez-Medrano, F.; Ruiz-Contreras, J.; Aguado, J. M.  [Vaccination Against Streptococcus Pneumoniae in Solid Organ Transplant Recipients.].   Enferm Infecc Microbiol Clin; April 8, 2009. [Epub ahead of print].

  31. Ganczak, M.; Szych, Z.; Korzen, M.  Preoperative Vaccination for HBV at Polish Hospitals As a Possible Public Health Tool to Limit the Spread of the Epidemic: A Cross-Sectional Study.   Vaccine; April 30, 2009. [Epub ahead of print].

  32. Gnadinger, M.; Gassner, M.; Bachmann, G.  Attitudes Towards Vaccination.   Swiss Med Wkly; 139 (13-14): 212; April 4, 2009.

  33. Goel, N. K.; Pathak, R.; Galhotra, A.; Dankal, C.; Swami, H. M.  Pulse Polio Immunization in District Panipat: a Process Evaluation.   Indian J Pediatr; 76 (1): 29-32; January, 2009.

  34. Gomez, S. Y.; Ocazionez, R. E.  [Yellow Fever Virus 17D Neutralising Antibodies in Vaccinated Colombian People and Unvaccinated Ones Having Immunity Against Dengue.].   Rev Salud Publica (Bogota); 10 (5): 796-807; November, 2008.

  35. Goodyear-Smith, F.; Grant, C.; Petousis-Harris, H.; Turner, N.  Immunization Champions: Characteristics of General Practitioners Associated With Better Immunization Delivery.   Hum Vaccin; 5 (6); June 9, 2009. [Epub ahead of print].

  36. Gruslin, A.; Steben, M.; Halperin, S.; Money, D. M.; Yudin, M. H.  Immunization in Pregnancy: No. 220, December 2008.   Int J Gynaecol Obstet; 105 (2): 187-191; May, 2009.

  37. Guimaraes, T. M.; Alves, J. G.; Tavares, M. M.  [Impact of Immunization Measures by the Family Health Program on Infant Mortality From Preventable Diseases in Olinda, Pernambuco State, Brazil].   Cad Saude Publica; 25 (4): 868-876; April, 2009.

  38. Hambleton, S.  The Role of Vaccination in Prevention of VZV Disease in the Immunocompromised Child.   Clin Adv Hematol Oncol; 7 (3): 159-161; March, 2009.

  39. Hampl, M.  [Value of General Human Papillomavirus Vaccination in Sexually Active Women].   Dtsch Med Wochenschr; 134 (Suppl 2): S95-S99; April, 2009.

  40. Harpaz, R.; Yawn, B. P.  Trends in Rates of Herpes Zoster-Related Hospitalizations: Are They Real, Are They Costly, and Are They Linked to Varicella Vaccination?   Infect Control Hosp Epidemiol; 30 (5): 495-496; May, 2009.

  41. Hong, R.; Chhea, V.  Trend and Inequality in Immunization Dropout Among Young Children in Cambodia.   Matern Child Health J; April 7, 2009. [Epub ahead of print].

  42. Hutt, H. J.; Kirch, W.  [Vaccinations: Strategies and Comprehension].   Dtsch Med Wochenschr; 134 (Suppl 2): S60; April, 2009.

  43. Italiano, C. M.; Toi, C. S.; Chan, S. P.; Dwyer, D. E.  Prolonged Varicella Viraemia and Streptococcal Toxic Shock Syndrome Following Varicella Vaccination of a Health Care Worker.   Med J Aust; 190 (8): 451-453; April, 2009.

  44. Jones, K. L.; Hammer, A. L.; Swenson, C.; Appel, A.; Phibbs, S.; Hill, F.; Kennedy, O.  Improving Adult Immunization Rates in Primary Care Clinics.   Nurs Econ; 26 (6): 404-407; November, 2008.

  45. Jones, S.; Evans, K.; Elwaine-Johnn, H.; Sharpe, M.; Oxford, J.; Lambkin-Williams, R.; Mant, T.; Nolan, A.; Zambon, M.; Ellis, J.; Beadle, J.; Loudon, P. T.  DNA Vaccination Protects Against an Influenza Challenge in a Double-Blind Randomised Placebo-Controlled Phase 1b Clinical Trial.    Vaccine; 27 (18): 2506-2512; April 21, 2009.

  46. Kim, J. K.  HPV Genotyping Prior to Vaccination Promise.   MLO Med Lab Obs; 41 (3): 36-37; March, 2009.

  47. Koyama, A.; Toida, I.; Nakata, S.  [Osteitis As a Complication of BCG Vaccination].   Kekkaku; 84 (3): 125-132; March, 2009.

  48. Lee, K.; Kim, H.; Shin, E.; Kim, Y.; Chang, S.; Choi, J.   Validity of Measles Immunization Certificates Submitted Upon Enrollment in an Elementary School in Korea.   J Prev Med Public Health; 42 (2): 104-108; March, 2009.

  49. Logan, J. L.  Disparities in Influenza Immunization Among US Adults.   J Natl Med Assoc; 101 (2): 161-166; February, 2009.

  50. MacDonald, N.; Picard, A.  [A Plea for Clear Language on Vaccine Safety].   CMAJ; 180 (7): E2-E3, 697-698; March 31, 2009.

  51. Marlow, L. A.; Waller, J.; Evans, R. E.; Wardle, J.  Predictors of Interest in HPV Vaccination: A Study of British Adolescents.   Vaccine; 27 (18): 2483-2488; April 21, 2009.

  52. Marshall, G. S.  Rotavirus Disease and Prevention Through Vaccination.   Pediatr Infect Dis J; 28 (4): 355-62, quiz; April, 2009.

  53. Martin, R.; Norgaard, O.; Lazarus, J. V.  European Immunization Week Goes Viral.   Euro Surveill; 14 (16): 19180; April 23, 2009.

  54. Massey, P. D.  Q-Fever Vaccination - Unfinished Business in Australia.   Vaccine; April 22, 2009. [Epub ahead of print].

  55. Masuda, M.; Sugita, S.; Kuroda, K.; Nishimura, H.  H5N1 Influenza Vaccination Policy in Japan.   Lancet Infect Dis; 9 (5): 266-267; May, 2009.

  56. Mathew, J. L.  Influenza Vaccination for Children in India.   Indian Pediatr; 46 (4): 304-307; April, 2009.

  57. Mathew, J. L.  Pneumococcal Vaccination in Developing Countries: Where Does Science End and Commerce Begin?   Vaccine; April, 2009. [Epub ahead of print].

  58. McElhaney, J. E.  Prevention of Infectious Diseases in Older Adults Through Immunization: the Challenge of the Senescent Immune Response.   Expert Rev Vaccines; 8 (5): 593-606; May, 2009.

  59. Mendrinos, E.; Baglivo, E.  Acute Posterior Multifocal Placoid Pigment Epitheliopathy Following Influenza Vaccination.   Eye; April 3, 2009. [Epub ahead of print].

  60. Millet, A.; Decaux, O.; Perlat, A.; Grosbois, B.; Jego, P.  Systemic Lupus Erythematosus and Vaccination.   Eur J Intern Med; 20 (3): 236-241; May, 2009.

  61. Mori, T.; Yamauchi, Y.  [Recent Problem of Skin Lesions Induced by BCG Vaccination].   Kekkaku; 84 (3): 109-115; March, 2009.

  62. Moszynski, P.  Rwanda Launches Vaccination Drive Against Pneumococcal Disease in Under 5s.   BMJ; 338: b1729; April 27, 2009.

  63. Nasiri, R.; Yoseffi, J.; Khajedaloe, M.; Sarafraz, Yazdi M.; Delgoshaei, F.  Congenital Rubella Syndrome After Rubella Vaccination in 1-4 Weeks Periconceptional Period.   Indian J Pediatr; 76 (3): 279-282; March, 2009.

  64. Nath, B.; Singh, J. V.; Awasthi, S.; Bhushan, V.; Singh, S. K.; Kumar, V.  Client Satisfaction With Immunization Services in Urban Slums of Lucknow District.   Indian J Pediatr; April 23, 2009. [Epub ahead of print].

  65. Nicholson, M. R.; Hayes, D. M.; Bennett, A. M.  Partnering With Nursing Service Improves Health Care Worker Influenza Vaccination Rates.   Am J Infect Control; April 9, 2009. [Epub ahead of print].

  66. Osaki, K.; Hattori, T.; Kosen, S.; Singgih, B.  Investment in Home-Based Maternal, Newborn and Child Health Records Improves Immunization Coverage in Indonesia.   Trans R Soc Trop Med Hyg; April 15, 2009. [Epub ahead of print].

  67. Paul, R.  Parents Ask: Am I Risking Autism If I Vaccinate My Children?   J Autism Dev Disord; 39 (6): 962-963; April 11, 2009.

  68. Protzel Berman, P.; Orenstein, W. A.; Hinman, A. R.; Gazmararian, J.  Stakeholder Attitudes Toward Influenza Vaccination Policy in the United States.   Health Promot Pract; April 3, 2009. [Epub ahead of print].

  69. Razeghinejad, M. R.; Nowroozzadeh, M. H.; Sharifi, M.; Monabati, A.  Acute-Onset Madarosis Following MMR Vaccination.   J Pediatr Ophthalmol Strabismus; 46 (2): 123-124; March, 2009.

  70. Rendi-Wagner, P.; Paulke-Korinek, M.; Kundi, M.; Burgmann, H.; Georgopoulos, A.; Vecsei, A.; Kollaritsch, H.  National Paediatric Immunization Program of High Risk Groups: No Effect on the Incidence of Invasive Pneumococcal Diseases.   Vaccine; April 22, 2009. [Epub ahead of print].

  71. Roberts, L.  Infectious Disease. Hitting Early, Epidemic Meningitis Ravages Nigeria and Niger.   Science; 324 (5923): 20-21; April 3, 2009.

  72. Rue-Cover, A.; Iskander, J.; Lyn, S.; Burwen, D. R.; Gargiullo, P.; Shadomy, S.; Blostein, J.; Bridges, C. B.; Haber, P.; Satzger, R. D.; Ball, R.; Seward, J. F.  Death and Serious Illness Following Influenza Vaccination: a Multidisciplinary Investigation.   Pharmacoepidemiol Drug Saf; April 16, 2009. [Epub ahead of print].

  73. Sa-Leao, R.; Nunes, S.; Brito-Avo, A.; Frazao, N.; Simoes, A. S.; Crisostomo, M. I.; Paulo, A. C.; Saldanha, J.; Santos-Sanches, I.; de Lencastre, H.  Changes in Pneumococcal Serotypes and Antibiotypes Carried by Vaccinated and Unvaccinated Day-Care Centre Attendees in Portugal, a Country With Widespread Use of the Seven-Valent Pneumococcal Conjugate Vaccine.   Clin Microbiol Infect; April 23, 2009. [Epub ahead of print].

  74. Salleras, L.; Dominguez, A.; Ciruela, P.; Izquierdo, C.; Borras, E.  [Impact of 7-Valent Pneumococcal Conjugate Vaccination in a Population With Low to Intermediate Vaccination Levels.].   Enferm Infecc Microbiol Clin; 27 (5): 275-277; April, 2009.

  75. Shim, E.; Galvani, A. P.  Impact of Transmission Dynamics on the Cost-Effectiveness of Rotavirus Vaccination.   Vaccine; April, 2009. [Epub ahead of print].

  76. Sinno, D. D.; Shoaib, H. A.; Musharrafieh, U. M.; Hamadeh, G. N.  Prevalence and Predictors of Immunization in a Health Insurance Plan in a Developing Country.   Pediatr Int; February 2, 2009. [Epub ahead of print].

  77. Stafford, N.  Germany Reviews Its Policy on HPV Vaccination for 12-17 Year Olds.   BMJ; 338: b1692; April 27, 2009.

  78. Stahl, J. P.  [European Week for Vaccination.].   Med Mal Infect; 39 (4): 211; April, 2009.

  79. Strady, C.; Andreoletti, L.; Baumard, S.; Servettaz, A.; Jaussaud, R.; Strady, A.  Immunogenicity and Booster Efficacy of Pre-Exposure Rabies Vaccination.   Trans R Soc Trop Med Hyg; April 7, 2009. [Epub ahead of print].

  80. Talbot, H. K.; Poehling, K. A.; Williams, J. V.; Zhu, Y.; Chen, Q.; McNabb, P.; Edwards, K. M.; Griffin, M. R.  Influenza in Older Adults: Impact of Vaccination of School Children.   Vaccine; 27 (13): 1923-1927; March 18, 2009.

  81. Toikka, P.; Helminen, M.; Rajalahti, I.; Valve, K.; Korppi, M.  [Infantile Tuberculosis--to Be Considered Again].   Duodecim; 125 (1): 73-77; 2009.

  82. Ueda, K.  Development of the Rubella Vaccine and Vaccination Strategy in Japan.   Vaccine; March 5, 2009. [Epub ahead of print].

  83. Vardeny, O.; Sweitzer, N. K.; Detry, M. A.; Moran, J. M.; Johnson, M. R.; Hayney, M. S.  Decreased Immune Responses to Influenza Vaccination in Patients With Heart Failure.   J Card Fail; 15 (4): 368-373; May, 2009.

  84. Wahle, K.  [Responsibilities of the General Practitioner in Vaccination Control].   Dtsch Med Wochenschr; 134 (Suppl 2): S65-S70; April, 2009.

  85. Weinke, T.; Guthoff, W.  [Influenza and Pneumococcal Vaccination in Adults].   Dtsch Med Wochenschr; 134 (Suppl 2): S82-S85; April, 2009.

  86. Wilson, K.; Barakat, M.; Vohra, S.; Ritvo, P.; Boon, H.  Parental Views on Pediatric Vaccination: the Impact of Competing Advocacy Coalitions.   Public Underst Sci; 17 (2): 231-243; April, 2008.

  87. Wooten, K. G.; Janssen, A.; Smith, P. J.; Pickering, L. K.  Associations Between Childhood Vaccination Status and Medical Practice Characteristics Among White, Black, and Hispanic Children.   J Natl Med Assoc; 101 (3): 229-235; March, 2009.

  88. Wutzler, P.  [Herpes Zoster and Postherpetic Neuralgia - Prevention by Vaccination?].   Dtsch Med Wochenschr; 134 (Suppl 2): S90-S94; April, 2009.

  89. Yamada, A. F.; Pellegrini, J. B.; Cunha, L. M.; Fernandes, Ada R.  [Osteitis After BCG Vaccination].   J Bras Pneumol; 35 (3): 285-289; March, 2009.

  90. Yildirim, C.; Kucuk, A. I.; Ongut, G.; Ogunc, D.; Colak, D.; Mutlu, G.  [Evaluation of Tuberculin Reactivity in Different Age Groups With and Without BCG Vaccination].   Mikrobiyol Bul; 43 (1): 27-35; January, 2009.

  91. Yu, H.; Farrar, J.  Hongjie Yu: Monitoring Avian Influenza in China. Interview by Mark Honigsbaum.   Lancet; 373 (9671): 1243; April 11, 2009.